China National Accord Medicines Corp Ltd
SZSE:000028
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
China National Accord Medicines Corp Ltd
SZSE:000028
|
CN |
Relative Value
The Relative Value of one China National Accord Medicines Corp Ltd stock under the Base Case scenario is 78.87 CNY. Compared to the current market price of 25.18 CNY, China National Accord Medicines Corp Ltd is Undervalued by 68%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
Competitors Multiples
China National Accord Medicines Corp Ltd Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
C
|
China National Accord Medicines Corp Ltd
SZSE:000028
|
13.6B CNY | 0.2 | 26.2 | 21.8 | 21.8 | |
| US |
|
Mckesson Corp
NYSE:MCK
|
108.5B USD | 0.3 | 25 | 17.6 | 19.7 | |
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
63B USD | 0.2 | 38.8 | 13.7 | 17.3 | |
| US |
|
Cencora Inc
NYSE:COR
|
63.7B USD | 0.2 | 39.2 | 13.9 | 17.5 | |
| US |
|
Cardinal Health Inc
NYSE:CAH
|
48.9B USD | 0.2 | 29.4 | 14.2 | 18.5 | |
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
29.9B AUD | 2.6 | 32.9 | 24.5 | 24.5 | |
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
60.4B CNY | 0.2 | 10.8 | 14.8 | 14.8 | |
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
8.6B USD | 0.6 | 21.5 | 10.5 | 14.7 | |
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
58.9B CNY | 1.4 | 16.1 | 12.4 | 12.4 | |
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 5.9 | 89.6 | 59.9 | 61.9 | |
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
63.7B HKD | 0.1 | 7.9 | 1.4 | 1.7 |